Big, nontraditional biotech companies such as Corning Inc., Motorola Inc. and Agilent Technologies Inc. are lining up to compete in the microarray market, offering instrumentation as well as arrays themselves. Protogene Laboratories Inc. anticipates that these big competitors will market their solutions to vice president-level decision makers who will make purchasing decisions for entire companies or institutions. Protogene hopes to duck under this approach and capture market share by offering high quality custom arrays to directors of individual laboratories.

"We want to come in under their radar," said Christopher Wolf, president and CEO.